52 related articles for article (PubMed ID: 22423483)
21. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
Yin F; Giuliano AE; Law RE; Van Herle AJ
Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771
[TBL] [Abstract][Full Text] [Related]
22. Role of transforming growth factor beta in rat bladder smooth muscle cell proliferation.
Barendrecht MM; Mulders AC; van der Poel H; van den Hoff MJ; Schmidt M; Michel MC
J Pharmacol Exp Ther; 2007 Jul; 322(1):117-22. PubMed ID: 17435108
[TBL] [Abstract][Full Text] [Related]
23. Phosphatidylinositol 3-kinase/Akt pathway is involved in transforming growth factor-beta1-induced phenotypic modulation of 10T1/2 cells to smooth muscle cells.
Lien SC; Usami S; Chien S; Chiu JJ
Cell Signal; 2006 Aug; 18(8):1270-8. PubMed ID: 16310342
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory effects of OD 78 [3-(4-bromo-phenoxy)-4,5-dihydroxybenzoic acid-methyl ester] on the proliferation and migration of TNF-α-induced rat aortic smooth muscle cells.
Lim Y; Tudev M; Park ES; Kim WS; Lim IH; Lee MY; Lee H; Jung JK; Hong JT; Yoo HS; Lee MK; Pyo MY; Yun YP
Arch Pharm Res; 2011 Jul; 34(7):1191-9. PubMed ID: 21811927
[TBL] [Abstract][Full Text] [Related]
25. Apigenin Inhibits Proliferation, Migration, and Invasion of Human Tongue Carcinoma Tca8113 Cells Through Regulating the MAPK Signaling Pathways.
Xuan YZ; Xu LZ; Jin CR; Yang KJ
Curr Mol Med; 2021; 21(8):690-697. PubMed ID: 33092506
[TBL] [Abstract][Full Text] [Related]
26. The chemopreventive bioflavonoid apigenin modulates signal transduction pathways in keratinocyte and colon carcinoma cell lines.
Van Dross R; Xue Y; Knudson A; Pelling JC
J Nutr; 2003 Nov; 133(11 Suppl 1):3800S-3804S. PubMed ID: 14608117
[TBL] [Abstract][Full Text] [Related]
27. Wiring diagrams of MAPK regulation by MEKK1, 2, and 3.
Uhlik MT; Abell AN; Cuevas BD; Nakamura K; Johnson GL
Biochem Cell Biol; 2004 Dec; 82(6):658-63. PubMed ID: 15674433
[TBL] [Abstract][Full Text] [Related]
28. Apigenin inhibition of involucrin gene expression is associated with a specific reduction in phosphorylation of protein kinase Cdelta Tyr311.
Balasubramanian S; Zhu L; Eckert RL
J Biol Chem; 2006 Nov; 281(47):36162-72. PubMed ID: 16982614
[TBL] [Abstract][Full Text] [Related]
29. A cryptic tubulin-binding domain links MEKK1 to curved tubulin protomers.
Filipčík P; Latham SL; Cadell AL; Day CL; Croucher DR; Mace PD
Proc Natl Acad Sci U S A; 2020 Sep; 117(35):21308-21318. PubMed ID: 32817551
[TBL] [Abstract][Full Text] [Related]
30. Generation of a human urinary bladder smooth muscle cell line.
Zheng Y; Chang S; Boopathi E; Burkett S; John M; Malkowicz SB; Chacko S
In Vitro Cell Dev Biol Anim; 2012 Feb; 48(2):84-96. PubMed ID: 22259013
[TBL] [Abstract][Full Text] [Related]
31. The flavonoid apigenin improves glucose tolerance through inhibition of microRNA maturation in miRNA103 transgenic mice.
Ohno M; Shibata C; Kishikawa T; Yoshikawa T; Takata A; Kojima K; Akanuma M; Kang YJ; Yoshida H; Otsuka M; Koike K
Sci Rep; 2013; 3():2553. PubMed ID: 23989853
[TBL] [Abstract][Full Text] [Related]
32. The Inhibitory Effect of Apigenin on the Agonist-Induced Regulation of Vascular Contractility via Calcium Desensitization-Related Pathways.
Je HD; Kim HD; La HO
Biomol Ther (Seoul); 2014 Feb; 22(2):100-5. PubMed ID: 24753814
[TBL] [Abstract][Full Text] [Related]
33. The Potential Role of Apigenin in Cancer Prevention and Treatment.
Rahmani AH; Alsahli MA; Almatroudi A; Almogbel MA; Khan AA; Anwar S; Almatroodi SA
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144783
[TBL] [Abstract][Full Text] [Related]
34. Plant flavone apigenin: An emerging anticancer agent.
Shankar E; Goel A; Gupta K; Gupta S
Curr Pharmacol Rep; 2017 Dec; 3(6):423-446. PubMed ID: 29399439
[TBL] [Abstract][Full Text] [Related]
35. A Biologically-Based Computational Approach to Drug Repurposing for Anthrax Infection.
Bai JP; Sakellaropoulos T; Alexopoulos LG
Toxins (Basel); 2017 Mar; 9(3):. PubMed ID: 28287432
[TBL] [Abstract][Full Text] [Related]
36. Chrysin inhibits tumor promoter-induced MMP-9 expression by blocking AP-1 via suppression of ERK and JNK pathways in gastric cancer cells.
Xia Y; Lian S; Khoi PN; Yoon HJ; Joo YE; Chay KO; Kim KK; Do Jung Y
PLoS One; 2015; 10(4):e0124007. PubMed ID: 25875631
[TBL] [Abstract][Full Text] [Related]
37. Antiestrogenic activity of flavonoid phytochemicals mediated via the c-Jun N-terminal protein kinase pathway. Cell-type specific regulation of estrogen receptor alpha.
Collins-Burow BM; Antoon JW; Frigo DE; Elliott S; Weldon CB; Boue SM; Beckman BS; Curiel TJ; Alam J; McLachlan JA; Burow ME
J Steroid Biochem Mol Biol; 2012 Oct; 132(1-2):186-93. PubMed ID: 22634477
[TBL] [Abstract][Full Text] [Related]
38. Apigenin inhibits cell migration through MAPK pathways in human bladder smooth muscle cells.
Liu Q; Chen X; Yang G; Min X; Deng M
Biocell; 2011 Dec; 35(3):71-9. PubMed ID: 22423483
[TBL] [Abstract][Full Text] [Related]
39. The dietary flavones apigenin and luteolin impair smooth muscle cell migration and VEGF expression through inhibition of PDGFR-beta phosphorylation.
Lamy S; Bédard V; Labbé D; Sartelet H; Barthomeuf C; Gingras D; Béliveau R
Cancer Prev Res (Phila); 2008 Nov; 1(6):452-9. PubMed ID: 19138992
[TBL] [Abstract][Full Text] [Related]
40. Adiponectin inhibits insulin-like growth factor-1-induced cell migration by the suppression of extracellular signal-regulated kinase 1/2 activation, but not Akt in vascular smooth muscle cells.
Motobayashi Y; Izawa-Ishizawa Y; Ishizawa K; Orino S; Yamaguchi K; Kawazoe K; Hamano S; Tsuchiya K; Tomita S; Tamaki T
Hypertens Res; 2009 Mar; 32(3):188-93. PubMed ID: 19262481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
